Vignola Mark J.

Vignola Mark J. is listed in filings as Chief Financial Officer at Terns Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2025, including sale activity. Recent filings connect the profile to Terns Pharmaceuticals, Inc. (TERN). The current snapshot covers public activity from Sep 12, 2024 to Jan 6, 2025. Reported amounts are shown as $52.5K to $110.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.